Literature DB >> 27052799

Accuracy of preoperative endometrial sampling diagnosis for predicting the final pathology grading in uterine endometrioid carcinoma.

T P Batista1, C L C Cavalcanti2, A A G Tejo2, A L R Bezerra3.   

Abstract

PURPOSE: To explore the accuracy of preoperative endometrial sampling diagnosis for predicting the final pathology grading in endometrial cancer.
METHODS: A cross-sectional study was carried out on patients who underwent surgical treatment for clinically early-stage endometrioid carcinoma of uterus at our Centers from March, 1991 to June, 2012. The agreement levels for the histological grading between the preoperative endometrial sampling diagnosis and the final surgical pathology were analyzed by the Kappa (κ) statistics with 95% confidence intervals (CI). The statistical analyses were also based on frequency data and diagnostic agreement of the procedures.
RESULTS: We retrospectively selected 79 patients that fit the criteria of this analysis. The overall level of agreement between preoperative and postoperative grading was "fair" according to Kappa (κ) statistics (κ = 0.221; 95%CI = 0.389-0.053; p = 0.01). Accordingly, the overall concordance was 48/79 (60.75%)-39/58 (67.24%) for G1, 7/16 (43.75%) for G2, and 2/5 (40%) for G3 tumors. The preoperative grade 1 diagnosis was upgraded to grade 2 (n = 6) or 3 (n = 1) in 15.2% of patients after hysterectomy. Sensitivity, specificity, NPV, PPV, and accuracy of preoperative endometrial sampling diagnosis to predict grade 1 at the final surgical pathology was 67.2%, 66.7%, 42.4%, 84.8% and 67.1%, respectively.
CONCLUSIONS: Preoperative endometrial sampling was found to be only a modest overall predictor of postoperative histological grading. A selective staging policy based on predictive models to avoid lymph node dissections in endometrial cancer should take into account additional parameters.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Dilatation and curettage; Endometrial neoplasm; Hysteroscopy; Lymphadenectomy; Neoplasm staging; Surgical pathology

Mesh:

Year:  2016        PMID: 27052799     DOI: 10.1016/j.ejso.2016.03.009

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  18 in total

1.  Neoadjuvant chemotherapy followed by surgery for advanced-stage endometrial cancer.

Authors:  N M de Lange; N P M Ezendam; J S Kwon; I Vandenput; D Mirchandani; F Amant; L J M van der Putten; J M A Pijnenborg
Journal:  Curr Oncol       Date:  2019-04-01       Impact factor: 3.677

2.  Accuracy of pre-operative hysteroscopic guided biopsy for predicting final pathology in uterine malignancies.

Authors:  Fabio Martinelli; Antonino Ditto; Giorgio Bogani; Mauro Signorelli; Valentina Chiappa; Domenica Lorusso; Edward Haeusler; Francesco Raspagliesi
Journal:  J Cancer Res Clin Oncol       Date:  2017-03-01       Impact factor: 4.553

3.  An MRI radiomics nomogram improves the accuracy in identifying eligible candidates for fertility-preserving treatment in endometrioid adenocarcinoma.

Authors:  Bi-Cong Yan; Feng-Hua Ma; Ying Li; Yan-Feng Fan; Zhi-Long Huang; Xiao-Liang Ma; Xue-Ting Wen; Jin-Wei Qiang
Journal:  Am J Cancer Res       Date:  2022-03-15       Impact factor: 6.166

4.  Molecular classification of endometrial carcinoma on diagnostic specimens is highly concordant with final hysterectomy: Earlier prognostic information to guide treatment.

Authors:  Aline Talhouk; Lien N Hoang; Melissa K McConechy; Quentin Nakonechny; Joyce Leo; Angela Cheng; Samuel Leung; Winnie Yang; Amy Lum; Martin Köbel; Cheng-Han Lee; Robert A Soslow; David G Huntsman; C Blake Gilks; Jessica N McAlpine
Journal:  Gynecol Oncol       Date:  2016-07-14       Impact factor: 5.482

Review 5.  Endometrial Cancer MRI staging: Updated Guidelines of the European Society of Urogenital Radiology.

Authors:  Stephanie Nougaret; Mariana Horta; Evis Sala; Yulia Lakhman; Isabelle Thomassin-Naggara; Aki Kido; Gabriele Masselli; Nishat Bharwani; Elizabeth Sadowski; Andrea Ertmer; Milagros Otero-Garcia; Rahel A Kubik-Huch; Teresa M Cunha; Andrea Rockall; Rosemarie Forstner
Journal:  Eur Radiol       Date:  2018-07-11       Impact factor: 5.315

Review 6.  New classification of endometrial cancers: the development and potential applications of genomic-based classification in research and clinical care.

Authors:  A Talhouk; J N McAlpine
Journal:  Gynecol Oncol Res Pract       Date:  2016-12-13

7.  Role of preoperative magnetic resonance imaging and histological assessment in identifying patients with a low risk of endometrial cancer: a Korean Gynecologic Oncology Group ancillary study.

Authors:  Jung-Yun Lee; Yun Hwan Kim; Jong-Min Lee; Kidong Kim; Sokbom Kang; Myong Cheol Lim; Beob-Jong Kim; Bang Hyun Lee; Jae Weon Kim
Journal:  Oncotarget       Date:  2017-11-20

8.  An Efficacious Endometrial Sampler for Screening Endometrial Cancer.

Authors:  Lu Han; Jiang Du; Lanbo Zhao; Chao Sun; Qi Wang; Xiaoqian Tuo; Huilian Hou; Yu Liu; Qing Wang; Qurat Ulain; Shulan Lv; Guanjun Zhang; Qing Song; Qiling Li
Journal:  Front Oncol       Date:  2019-02-19       Impact factor: 6.244

9.  Methylation status of KLF4 and HS3ST2 genes as predictors of endometrial cancer and hyperplastic endometrial lesions.

Authors:  Zuzana Danková; Dušan Braný; Dana Dvorská; Marcela Ňachajová; Roman Fiolka; Marián Grendár; Jozef Hatok; Peter Kubatka; Veronika Holubeková; Erika Halašová; Tibor Bielik; Pavol Žúbor
Journal:  Int J Mol Med       Date:  2018-09-12       Impact factor: 4.101

10.  Frozen section accurately allows pathological characterization of endometrial cancer in patients with a preoperative ambiguous or inconclusive diagnoses: our experience.

Authors:  A Santoro; A Piermattei; F Inzani; G Angelico; M Valente; D Arciuolo; S Spadola; M Martini; F Fanfani; A Fagotti; V Gallotta; G Scambia; G F Zannoni
Journal:  BMC Cancer       Date:  2019-11-12       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.